financetom
Business
financetom
/
Business
/
US tariff uncertainty weighs on Infineon's revenue outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US tariff uncertainty weighs on Infineon's revenue outlook
May 26, 2025 3:52 AM

FRANKFURT (Reuters) -German chipmaker Infineon Technologies reported stable order intake on Thursday but lowered its full-year revenue outlook due to uncertainty over global tariff disputes.

U.S. President Donald Trump has said tariffs on semiconductor chips would start at "25%, or higher," rising substantially over the course of a year, but has not specified when these would come into effect, putting chipmakers in limbo.

"Given that order intake still shows no signs at all of slowing down, we can only guesstimate the effects of tariff disputes," CEO Jochen Hanebeck said in a statement.

He added the company had applied a haircut of 10% of expected revenue in the last quarter of its fiscal year, which ends on September 30.

In its 2024 fiscal year, revenue came in at 15 billion euros ($17 billion). Infineon previously expected flat or slightly higher revenue this year.

"Without the haircut the forecast would have remained essentially unchanged," Infineon said, adding that new exchange rate assumptions also weighed on its outlook.

Infineon now expects an operating margin in the mid-teens percentage range, narrowing down the previous mid-to-high-teens range.

($1 = 0.8860 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Karyopharm's drug reduces spleen size in rare blood cancer study
Karyopharm's drug reduces spleen size in rare blood cancer study
Mar 24, 2026
March 24 (Reuters) - Karyopharm Therapeutics ( KPTI ) said on Tuesday its therapy for patients with a rare blood cancer showed a reduction in spleen size in a late-stage trial, meeting one of the two main goals of the study. Shares of the company were up nearly 14% in premarket trade. In the 353-patient trial, half of those given...
Core & Main Fiscal Q4 Adjusted Earnings Increase, Net Sales Decrease; Fiscal 2026 Sales Guidance Initiated
Core & Main Fiscal Q4 Adjusted Earnings Increase, Net Sales Decrease; Fiscal 2026 Sales Guidance Initiated
Mar 24, 2026
08:11 AM EDT, 03/24/2026 (MT Newswires) -- Core & Main ( CNM ) reported fiscal Q4 adjusted earnings Tuesday of $0.52 per diluted share, up from $0.51 a year earlier. Analysts polled by FactSet expected $0.48. Net sales for the fiscal quarter ended Feb. 1 were $1.58 billion, down from $1.70 billion a year earlier. Analysts surveyed by FactSet expected...
BRIEF-1Gt Portfolio Investment Huel To Be Acquired By Danone
BRIEF-1Gt Portfolio Investment Huel To Be Acquired By Danone
Mar 24, 2026
Morgan Stanley ( MS ): * 1GT PORTFOLIO INVESTMENT HUEL TO BE ACQUIRED BY DANONE Source text: Further company coverage: ...
Peltz's Trian, General Catalyst raise offer for Janus Henderson
Peltz's Trian, General Catalyst raise offer for Janus Henderson
Mar 24, 2026
March 24 (Reuters) - Janus Henderson ( JHG ) said on Tuesday that Trian and General Catalyst have raised their bid to acquire the asset manager to $52 per share. The new offer, which represents a 25% premium to Janus' unaffected stock price and is $3 per share higher than the previous bid, comes amid a high-stakes battle with Victory...
Copyright 2023-2026 - www.financetom.com All Rights Reserved